ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

Also Von Eschenbach’s NCI Farewell Reception, Gift Solicitation, Raises Legal And Ethical Issues.

May 5, 2006

Finasteride For Prostate Cancer Prevention Causes Little Or No Sexual Dysfunction

August 31, 2007

Capitol Hill: Trial Results Represent Culmination of Research, Klausner Tells House

March 19, 1999

NCI advisors complete terms on board, Appelbaum’s term as BSA chairman ends.

July 23, 2004

Prostate Cancer: NIH “Misjudged” Time Needed To Write a Plan, Varmus Says

April 30, 1999

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014